Eleos Health vs Lyssn

Both vendors quote prices only to organizations, and neither lists one. Eleos documents sessions, scans every note for compliance and adds guardrails before claims go out, which suits a 40-clinician community agency whose payer denies claims over documentation gaps. It states SOC 2 Type II and claims faster symptom reduction (vendor claim), and a 2023 JMIR randomized trial on depression and anxiety symptoms matches that claim. A training director who needs session-quality scores gets nothing like that from Eleos. Lyssn is built for that director: it grades recorded sessions against more than 75 measures (vendor figure) and runs scored practice modules. Its documentation is an optional add-on, no EHR is named, and aggregators disagree on its funding, from $2M to $8.42M, mostly government grants. An agency chasing denied claims should treat Lyssn as the weaker fit.